These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 282087)

  • 1. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
    Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinins and prostaglandins in hypertension.
    Abe K
    Clin Endocrinol Metab; 1981 Nov; 10(3):577-605. PubMed ID: 6284417
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
    Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K
    Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 7. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on renal prostaglandin E in essential hypertension: relationships among urinary prostaglandin E, sodium balance, renin-angiotensin-aldosterone system and renal kallikrein-kinin system (author's transl)].
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Seino M; Sakurai Y; Saito K; Kusaka T; Imai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1537-45. PubMed ID: 744897
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
    Hahn JA; Zipser RD; Barg A; Stone RA; Zia PK; Hsueh WA; Horton R
    Prostaglandins Med; 1981 Jun; 6(6):549-56. PubMed ID: 6267637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the renin-aldosterone response to furosemide by indomethacin.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):174-6. PubMed ID: 874065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
    Mackay IG; Nath K; Cumming AD; Muir AL; Watson ML
    Clin Sci (Lond); 1985 Feb; 68(2):159-64. PubMed ID: 3881208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kallikrein-kinin system and prostaglandins in the kidney: their relation to forosemide-induced diuresis and to the renin-angiotensin-aldosterone system in man.
    Abe K; Irokawa N; Yasujima M; Seino M; Chiba S; Sakurai Y; Yoshinaga K; Saito T
    Circ Res; 1978 Aug; 43(2):254-60. PubMed ID: 668057
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium balance, plasma renin, and aldosterone in hypertension.
    Doyle AE; Jerums G
    Circ Res; 1970 Oct; 27():Suppl 2:267+. PubMed ID: 5506145
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral determinants of Na+ excretion after intravenous NaCl loading in normal volunteers.
    Stokes GS; Johnston HJ; Monaghan JC
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):310-2. PubMed ID: 8324915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of renal prostaglandins and relationship to renin, aldosterone, and antidiuretic hormone during salt depletion in man.
    Glasson P; Gaillard R; Riondel A; Vallotton MB
    J Clin Endocrinol Metab; 1979 Aug; 49(2):176-81. PubMed ID: 457838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.